McEwen Award for Innovation
The McEwen Award for Innovation, supported by the McEwen Centre
for Regenerative Medicine in Toronto, Ontario Canada, recognizes
original thinking and ground-breaking research pertaining to stem cells
or regenerative medicine that opens new avenues of exploration towards
the understanding or treatment of human disease or affliction.
The winner will be honored with the award at the
ISSCR 11th Annual Meeting in Boston in June
| || |
The 2014 McEwen Award for Innovation will be presented to Azim Surani, PhD, Wellcome Trust/Cancer Research UK Gurdon Institute, in recognition of his work on the cellular and molecular specification of the mammalian germ cell lineage. His research has helped uncover how the germ line is established and what molecular mechanisms are responsible for reprogramming the epigenome to achieve the totipotent state. Dr. Surani will be presented with his award during the Presidential Symposium on Wednesday, June 18, 2014.
- Nominee(s) must be independent investigators conducting original
research in basic science or clinical development and translation in the
field of stem cell research.
- At least one nominee must be available to attend the ISSCR Annual
Meeting if selected as the award recipient.
- The research recognized should have occurred within the past ten
years, but the body of work will also be considered.
- The award can be given to an individual OR can be shared for the
same advance by up to three people total and is not limited to the senior
Principal Investigator. A key junior collaborator who was in the lab of the PI at the
time of the discovery can be included with the Principal Investigator in the
- Nominee(s) must be an ISSCR member in good standing.
The winner will receive $100,000 USD (to be split among winners
if more than one person receives the award), a complimentary
registration for the Annual Meeting, and recognition at the Annual
Meeting during a plenary session.
Nominations must be sponsored by two or more people. Nomination letters may be submitted individually or as a single, co-signed letter. Nomination letter(s) (up to two pages) should provide the following:
A copy of the nominee’s CV(s) and listing of up to five of
their most relevant publications must also accompany the nomination
letter. Include an electronic version of these publications where
| ||2013 Winner. |
James A. Thomson, PhD is the recipient of the 2013 McEwen Award for Innovation. He is honored for his work that reproducibly isolated pluripotent cell lines from human blastocysts. This discovery opened the door for the study of human embryonic stem cells and revealed new possibilities for developing cell-based therapies, disease models and reagents for toxicity testing. Dr. Thomson is the Director of Regenerative Biology at the Morgridge Institute for Research in Madison Wisconsin and holds professorships at both the University of Wisconsin School of Medicine and Public Health and the University of California, Santa Barbara. He was presented with his award at the ISSCR 11th Annual Meeting in Boston, Massachusetts, USA, during the Presidential Symposium on Wednesday, June 12 and was immediately followed by his plenary lecture.
| || |
The recipient of the 2012 McEwen Award for
Innovation is Rudolf Jaenisch, MD, a leader in
biomedical sciences for more than three decades. Dr. Jaenisch is a
Founding Member of the Whitehead Institute for Biomedical Research and
Professor of Biology at the Massachusetts Institute of Technology.
He is recognized for his pioneering discoveries in the areas
of genetic and epigenetic control of development in mice that directly
impact the future potential of embryonic stem cells and induced
pluripotent stem cells for therapeutic utility and has made many seminal
discoveries in the fields of virology, cancer, epigenetics and
regenerative medicine. Dr. Jaenisch was presented with the
award preceding his keynote lecture on Wednesday, June 13,
| || |
Winners. The recipients of the 2011
inaugural McEwen Award for Innovation were Kazutoshi
Takahashi, PhD, lecturer, Center for iPS Cell Research and
Application, Kyoto University and Shinya Yamanaka, MD,
PhD, director, Center for iPS Cell Research and Application,
and Institute for Integrated Cell-Material Sciences, Kyoto University.
The award was given in recognition of their paradigm-shifting work
demonstrating the reprogramming of adult/tissue-specific cells using
transcription factors that has resulted in a rapid development of novel
tools and strategies for use in the pursuit of better understanding and